TrialX
Image

Manhattan Vision Screening and Follow-Up Study

Manhattan Vision Screening and Follow-Up Study

Recruiting
40 years and older
All
Phase N/A

Overview

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

Description

This study aims to increase engagement, detection and management of glaucoma, vision impairment, cataracts, and other eye diseases in vulnerable populations living in New York City. This study considers disparities by race, ethnicity, gender, geography, and socioeconomic status using innovative approaches such as patient navigators. Individuals over the age of 40 living in New York City Housing Authority (NYCHA) Housing buildings are eligible.

Eligibility

Inclusion Criteria:

  • Individuals over age 40
  • Living independently in NYCHA housing building.
  • Willing to consent for 3 vision screening visits at baseline, 12-month, and 24-month follow-up

Exclusion Criteria:

  • Self-reported terminal illness with life expectancy less than 1 year
  • Inability to provide informed consent due to dementia or other reasons

Study details
    EYE DISORDER
    Cataract
    Ocular Hypertension
    Ocular Hypertension
    Glaucoma
    Glaucoma
    Diabetic Retinopathy
    Diabetic Retinopathy
    Diabetic Macular Edema
    Diabetic Macular Edema
    Vision Impairment and Blindness

NCT04271709

Columbia University

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.